Search
Now showing items 1-1 of 1
Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group
Stilgenbauer, Stephan et al. (2009)
Beitrag zu einer Konferenz